Category:
Keywords:
Age Of Onset; Antineoplastic Agent; Antineoplastic Agents; Cancer Survival; Child; Childhood Cancer; Consensus Development; Counterfeit Drug; Cytotoxic Agent; Delivery Of Health Care, Integrated; Drug Cost; Drug Manufacture; Drug Marketing; Drug Quality; Drug Safety; Essential Drug; Health Care Access; Health Care Availability; Health Care Delivery; Health Services Accessibility; Human; Humans; Integrated Health Care System; Medical Oncology; Neoplasm; Neoplasms; Note; Oncology; Onset Age; Patient Advocacy; Practice Guideline; Priority Journal; Supply And Distribution; Global
